Sector in focus: Laboratory diagnostics – Growth beyond consolidation

With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.

Speakers include:

Joe Stringer, Executive Chairman, Automata

Case Study: The future of automation in labs, Automata, and The Royal Marsden
With the demand for genomic testing on the back of screening programs exploding, how are lab groups managing to keep up? Lab automation group, Automata has enabled providers such as a The Royal Marsden NHS Trust to increase genomic test throughput by 3 to 5x whilst simultaneously halving the space required. In this case study Joe explains how this was possible, the future of innovation in laboratories, the impact on the scientific workforce and productivity, and why logistics is now the only significant barrier to scaling innovation.

Jean-Francois Pomerol, CEO & Co-Founder, Tribun Health
Jérôme Thill, Partner, Horasis
Moderated by Dr Stephan Rau, Partner, McDermott, Will & Emery

Speakers

Joe StringerExecutive ChairmanAutomata

Jean-François PomerolChief Executive Officer & Co-FounderTribun Health

Jérôme ThillPartnerHorasis Partners

Dr Stephan RauPartnerMcDermott Will & Emery

Sector in focus: Diagnostic imaging

This sector has seen a huge M&A boom as investors continue to consolidate particularly in Western Europe. Governments are also pumping money into the sector to increase access to diagnosis and bring down waiting times. Groups are adopting new models to integrate more services and offerings for the patient. The impact of digital transformation and AI is advanced in the sector particularly for efficiency and productivity. This session shares examples through case studies of how this innovation is driving quality and access and changing the business model and what this means for providers and investors

Speakers include:

Dr Arjun Kalyanpur, CEO, Teleradiology Solutions
Zisis Sotiriou, Group Chief Operating Office, evidia
Antoine Jomier, CEO & Founder, Incepto Medical
Moderated by Chris O’Donnell, Head of Content, HBI

Speakers

Dr Arjun KalyanpurCEO / FounderTeleradiology Solutions

Zisis SotiriouGroup COOEvidia

Antoine JomierCEO & Co FounderIncepto Medical

Chris O'DonnellHead of ContentHBI

From reactive to proactive: How data and prevention are re-shaping healthcare business models

The global push for a preventative versus reactive approach to healthcare combined with digital technology is altering the business model for all healthcare providers. Each has the opportunity to leverage their data to open up new revenue streams, cut costs and build better relationships with payors and directly with patients. For years lab service and hospital groups have sat on huge data repositories of valuable data but lacked the business models needed to turn this into something that could drive topline growth, until now. This session explores three business models that generate value from screening and routine testing and explores exactly how technology is enabling these models to be both scalable and sustainable.

Rick VanNess, Director, Product Group, Rhodes Group
Nelli Såger, Development Director, Mehiläinen
Moderated by Dr Matthew Prime, Global Medical Director, Roche Diagnostic Information Solutions

Speakers

Rick VanNessDirector of Product DevelopmentTriCore Reference Laboratories, Albuquerque, NM

Nelli SågerDevelopment DirectorMehiläinen

Dr Matthew PrimeHead of Healthcare Expertise & Evidence Generation Roche Information Solutions